Research Articles
GLIPR1-ΔTM and Docetaxel: A Powerful Alliance Against Prostate Cancer
Discover how GLIPR1-ΔTM synergizes with docetaxel to enhance cell death and suppress resistance in prostate cancer treatment.
How a Tiny RNA Molecule Influences Breast Cancer Growth
Discover how microRNA-421 and PDCD4 interact to influence breast cancer progression, with implications for diagnosis and treatment.
Double-Barrel Attack: Simultaneously Targeting ErbB1 and ErbB2 to Combat Cholangiocarcinoma
Preclinical assessment of simultaneous targeting of epidermal growth factor receptor (ErbB1) and ErbB2 as a strategy for cholangiocarcinoma therapy
A New Guard for the Eyes: How a Common Cholesterol Drug Could Combat Diabetic Blindness
Discover how fenofibrate, a common cholesterol drug, shows promise in protecting against diabetic retinopathy by reducing oxidative stress in retinal cells.
Stopping Cancer in Its Tracks: How a Novel Compound Fights Colon Cancer Spread
Discover how the Alphavbeta3 integrin antagonist S247 decreases colon cancer metastasis and angiogenesis while improving survival in mice.
MLAA-22: The 'Smart Bomb' Antigen Revolutionizing Leukemia Treatment
Discover how MLAA-22, a novel antigen identified through computational biology, is transforming leukemia treatment with its precision targeting capabilities.
The Cell's Delayed Death Sentence: How a Cancer Drug Strikes with Perfect Timing
Discover how Interferon-alpha triggers cancer cell apoptosis through a sophisticated delayed timing mechanism during the cell cycle.
The miR-34a Enigma: How a Tiny Molecule Influences a Viral Cancer
Exploring the complex relationship between miR-34a and HTLV-1 infection in T-cells and its role in cancer development.
Cellular Text Messages: How Pancreatic Beta-Cells Communicate via Exosomal MicroRNAs
Discover how pancreatic beta-cells communicate through exosomal microRNAs and their role in diabetes progression through horizontal transfer of genetic material.
A Cellular Tug-of-War: How a New Drug Could Outsmart a Tenacious Blood Cancer
Discover how Aurkin-A, a novel TPX2-Aurora A inhibitor, disrupts alisertib-induced polyploidy in high-grade diffuse large B-cell lymphoma, offering new hope for cancer treatment.